Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2082138 | 1.00 | STAT3 (0.41) | STAT3HTTCYP3A4ADRB2TSHR | |
| SCHEMBL2078701 | 0.89 | STAT3 (0.43) | STAT3HTTCYP3A4ADRB2TSHR | |
| SCHEMBL2078703 | 0.89 | STAT3 (0.43) | STAT3HTTCYP3A4ADRB2TSHR | |
| SCHEMBL2083988 | 0.87 | CYP3A4 (0.47) | CYP3A4KMT2AGSK3BKDM4EALDH1A1 | |
| SCHEMBL2083990 | 0.87 | CYP3A4 (0.47) | CYP3A4KMT2AGSK3BKDM4EALDH1A1 | |
| SCHEMBL2083805 | 0.85 | POLB (0.40) | STAT3HTTCYP3A4ADRB2TSHR | |
| SCHEMBL2083807 | 0.85 | POLB (0.40) | STAT3HTTCYP3A4ADRB2TSHR | |
| SCHEMBL4675220 | 0.82 | STAT3 (0.40) | STAT3HTTCYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL2080449 | 0.81 | CYP3A4 (0.49) | STAT3HTTCYP3A4ADRB2KMT2A | |
| SCHEMBL2080448 | 0.81 | CYP3A4 (0.49) | STAT3HTTCYP3A4ADRB2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902226-B2 | Dehalogeno-compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2011-03-08 | — | — | US | disclosed |
| EP-1336611-B1 | DEHALOGENO COMPOUNDS | DAIICHI SEIYAKU CO (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20070123560-A1 | Dehalogeno-compounds | DAIICHI PHARMACEUTICAL CO., LTD. | 2007-05-31 | — | — | US | disclosed |
| US-20040063754-A1 | Dehalogeno compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1336611-A1 | DEHALOGENO COMPOUNDS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063754-A1 | Dehalogeno compounds | DEK, PGLS, RPS27L | STAT3 3955/4885HTT 1371/4885CYP3A4 198/4885 |
| US-20070123560-A1 | Dehalogeno-compounds | DEK, RPS27L, POLL | STAT3 4101/4885HTT 1526/4885CYP3A4 277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.